Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population

Greenlee, 2001, Cancer statistics, 2001, CA Cancer J. Clin., 51, 15, 10.3322/canjclin.51.1.15 INCA (Instituto Nacional do Câncer)-Ministério da Saúde. http://www.inca.org.br Estimativa de incidência e mortalidade por câncer no Brasil referente a 1996–2001. Rio de Janeiro; 2001. Jenster, 1999, The role of the androgen receptor in the development and progression of prostate cancer, Semin. Oncol., 26, 407 Irvine, 1995, The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer, Cancer Res., 55, 1937 Hsing, 2000, Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China, Cancer Res., 60, 5111 La Spada, 1991, Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy, Nature, 352, 77, 10.1038/352077a0 Chamberlain, 1994, The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function, Nucleic Acids Res., 22, 3181, 10.1093/nar/22.15.3181 Giovannucci, 1997, The CAG repeat within the androgen receptor gene and its relationship to prostate cancer, Proc. Natl. Acad. Sci. U.S.A., 94, 3320, 10.1073/pnas.94.7.3320 Hakimi, 1997, Androgen receptors variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer, Clin. Cancer Res., 3, 1599 Ingles, 1997, Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor, J. Natl. Cancer Inst., 89, 166, 10.1093/jnci/89.2.166 Stanford, 1997, Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk, Cancer Res., 57, 1194 Mondugno, 2001, Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk, Clin. Cancer Res., 7, 3092 Hardy, 1996, Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset, J. Clin. Endocrinol. Metabol., 81, 4400, 10.1210/jc.81.12.4400 Bratt, 1999, CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk, Br. J. Cancer, 81, 672, 10.1038/sj.bjc.6690746 Beilin, 2001, A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects, Cancer, 92, 941, 10.1002/1097-0142(20010815)92:4<941::AID-CNCR1404>3.0.CO;2-P Latil, 2001, Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways, Cancer, 92, 1130, 10.1002/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B Hosmer Jr DW, Lemeshow S. Applied logistic regression. New York: Wiley; 1989. STATA (statistical software). Release 7.0. Texas: Stata Corporation College Station; 2001. Correa-Cerro, 1999, (CAG) nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population, Eur. J. Hum. Genet., 7, 357, 10.1038/sj.ejhg.5200298 Edwards, 1999, Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival, Int. J. Cancer, 84, 458, 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y Sartor, 1999, Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer, Urology, 53, 378, 10.1016/S0090-4295(98)00481-6 Platz, 2000, Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals, J. Natl. Cancer Inst., 92, 2009, 10.1093/jnci/92.24.2009 Alves-Silva, 1999, Multiple geographic sources of region V 9-bp deletion haplotypes in Brazilians, Hum. Biol., 71, 245